Pregled bibliografske jedinice broj: 880253
Vitiligo Treatment Guidelines - Where are We Now?
Vitiligo Treatment Guidelines - Where are We Now? // Journal of Pigmentary Disorders, 11 (2015), 11-11 doi:10.4172/2376-0427.S11-011 (podatak o recenziji nije dostupan, kratko priopcenje, znanstveni)
CROSBI ID: 880253 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vitiligo Treatment Guidelines - Where are We Now?
Autori
Stanimirović, Andrija
Izvornik
Journal of Pigmentary Disorders (2376-0427) 11
(2015);
11-11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni
Ključne riječi
vitiligo ; treatment ; nowadays
Sažetak
Although vitiligo is an asymptomatic disease, it can have severe consequences on patients? quality of life and physical health. Available treatment options are aimed on stopping of the disease spreading, induction of repigmentation and achieving of sufficient cosmetic results. Vitiligo is neither contagious nor life threatening disease so it is often widely assumed that problems which affect the patients just have a cosmetic nature. Due to this matter, vitiligo is considered as an orphan disease and unfortunately, many physicians (including dermatologists) still consider vitiligo to be an incurable disease and are not familiar with available therapeutic options. Here we present five therapeutic algorithms for vitiligo treatment constituted from different worldwide working groups and organizations in the last few years. The following therapeutic options include mainly topical corticosteroids, topical calcineurin inhibitors, topical vitamin D3 analogues, phototherapy (PUVA and NBUVB), oral corticosteroids, antioxidants, laser and surgical therapy. A group of British authors established algorithm for the management of vitiligo in adults and children by non- specialists in 2010. One year after, group of authors from USA suggests their algorithm for dermatologists. The European Dermatology Forum Consensus presented algorithms for the management of patients with nonsegmental or segmental vitiligo in 2013, the same year when Japanese authors provided their proposal of the algorithm for the management of vitiligo in Japan. Considering available guidelines for the management of vitiligo, both available and unavailable therapeutic options in Croatia, and our clinical experience we have established our guidelines for the management of vitiligo in Croatia in 2014. This proposal and selection of specific therapeutic options in several lines are based on international up-to-date guidelines in accordance with evidence based medicine.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti